Skip to main content
. 2020 May 27;11:794. doi: 10.3389/fphar.2020.00794

Table 2.

Bayesian acceptable ranges of AUC0–24h used for dose individualization (Svensson et al., 2019).

Time after first dose (days) AUC0–24h (h. mg/L)
1 342–408
7 217–259
14 189–224
28 182–215
56 181–214

AUC0–24h, area under the plasma concentration-time curve from time zero up to 24 h.